pharmaphorum1mon
Galderma adds new indication for blockbuster hope Nemluvio
Earlier this year, Switzerland-based Galderma got its first approval for another blockbuster hopeful – botulinum toxin product Relfydess (relabotulinumtoxinA) – that is a rival to AbbVie ...
Business Wire1mon
Galderma Receives U.S. FDA Approval for Nemluvio ® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD ... 12 The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion on December ...
Business Wire1mon
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and ...
pharmaphorum5mon
Galderma gets FDA nod for prurigo nodularis therapy
The FDA approval comes after Switzerland-based Galderma got its first approvals for its other blockbuster hopeful – botulinum toxin product Relfydess (relabotulinumtoxinA) – in Australia ...
Yahoo Finance10mon
Galderma Group N (GALD.SW)
This follows the recent U.S. FDA approval of Nemluvio for subcut ZUG, Switzerland, December 13, 2024--Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP ...
Armed robbery in Revesby10d
Galderma Reports Success in Injectable Aesthetics Study
"We initiated this trial because we have the unique expertise, capability, and products needed to rapidly respond to ... FLEMMING ØRNSKOV, M.D., MPH CHIEF EXECUTIVE OFFICER GALDERMA Three-month ...